Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer

Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer

Jul 8, 2024

Featuring perspectives from Dr Rebecca S Heist, Dr Luis Paz-Ares and Dr Jacob Sands, moderated by Dr Sands, including the following topics:

  • Introduction (0:00)
  • Integration of Antibody-Drug Conjugates (ADCs) into the Care of Patients with Non-Small Cell Lung Cancer (NSCLC) and HER2 Alterations — Dr Paz-Ares (1:28)
  • Emerging Role of TROP2-Targeted ADCs for NSCLC — Dr Sands (23:12)
  • Other Promising Targets for ADCs for Lung Cancer — Dr Heist (39:07)

CME information and select publications